冠動脈ガイドワイヤーのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2023年版）

当レポートでは、冠動脈ガイドワイヤーのパイプライン製品について調査分析し、各開発段階における製品の比較分析や、進行中の臨床試験についての情報を含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 冠状動脈ガイドワイヤー - パイプライン製品：開発段階別
• 冠状動脈ガイドワイヤー - パイプライン製品：地域別
• 冠状動脈ガイドワイヤー - パイプライン製品：規制経路別
• 冠状動脈ガイドワイヤー - パイプライン製品：推定承認日別
• 冠状動脈ガイドワイヤー - 進行中の臨床試験

第4章 冠状動脈ガイドワイヤー - 開発中のパイプライン製品：企業別

• 冠状動脈ガイドワイヤー企業 - パイプライン製品：開発段階別
• 冠状動脈ガイドワイヤー - パイプライン製品：開発段階別

第5章 冠状動脈ガイドワイヤーの企業と製品の概要

• Abbott Vascular Inc：企業の概要
  • Abbott Vascular Inc：パイプライン製品と進行中の臨床試験の概要
• APT Medical Inc：企業の概要
  • APT Medical Inc：パイプライン製品と進行中の臨床試験の概要
• Bioscan Technologies Inc.：企業の概要
  • Bioscan Technologies Inc.：パイプライン製品と進行中の臨床試験の概要
• Boston Scientific Corp：企業の概要
  • Boston Scientific Corp：パイプライン製品と進行中の臨床試験の概要
• Cardiovascular Systems Inc：企業の概要
  • Cardiovascular Systems Inc：パイプライン製品と進行中の臨床試験の概要
• CorMetrics LLC：企業の概要
  • CorMetrics LLC：パイプライン製品と進行中の臨床試験の概要
• Echopoint Medical Ltd：企業の概要
  • Echopoint Medical Ltd：パイプライン製品と進行中の臨床試験の概要
• ENDOMATERIALS：企業の概要
  • ENDOMATERIALS：パイプライン製品と進行中の臨床試験の概要
• Georgia Institute of Technology：企業の概要
  • Georgia Institute of Technology：パイプライン製品と進行中の臨床試験の概要
• Guided Interventions, LLC：企業の概要
  • Guided Interventions, LLC：パイプライン製品と進行中の臨床試験の概要
• Infrared Sciences Corp：企業の概要
  • Infrared Sciences Corp：パイプライン製品と進行中の臨床試験の概要
• Koninklijke Philips NV：企業の概要
  • Koninklijke Philips NV：パイプライン製品と進行中の臨床試験の概要
• MaRVis Technologies GmbH：企業の概要
  • MaRVis Technologies GmbH：パイプライン製品と進行中の臨床試験の概要
• Microbot Medical Ltd：企業の概要
  • Microbot Medical Ltd：パイプライン製品と進行中の臨床試験の概要
• MicroPort Scientific Corp：企業の概要
  • MicroPort Scientific Corp：パイプライン製品と進行中の臨床試験の概要
• NewMed Medical Co Ltd：企業の概要
  • NewMed Medical Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Nirtek Pty Ltd：企業の概要
  • Nirtek Pty Ltd：パイプライン製品と進行中の臨床試験の概要
• Opsens Inc：企業の概要
  • Opsens Inc：パイプライン製品と進行中の臨床試験の概要
• OVALUM Ltd：企業の概要
  • OVALUM Ltd：パイプライン製品と進行中の臨床試験の概要
• SoundBite Medical Solutions Inc：企業の概要
  • SoundBite Medical Solutions Inc：パイプライン製品と進行中の臨床試験の概要
• St. Jude Medical LLC：企業の概要
  • St. Jude Medical LLC：パイプライン製品と進行中の臨床試験の概要
• Terumo Corp：企業の概要
  • Terumo Corp：パイプライン製品と進行中の臨床試験の概要
• Terumo Interventional Systems：企業の概要
  • Terumo Interventional Systems：パイプライン製品と進行中の臨床試験の概要
• The Cleveland Clinic Foundation：企業の概要
  • The Cleveland Clinic Foundation：パイプライン製品と進行中の臨床試験の概要
• Three Rivers Cardiovascular Systems Inc：企業の概要
  • Three Rivers Cardiovascular Systems Inc：パイプライン製品と進行中の臨床試験の概要
• Transmural systems LLC：企業の概要
  • Transmural systems LLC：パイプライン製品と進行中の臨床試験の概要
• University of Illinois at Chicago：企業の概要
  • University of Illinois at Chicago：パイプライン製品と進行中の臨床試験の概要
• Vasostar Ltd.：企業の概要
  • Vasostar Ltd.：パイプライン製品と進行中の臨床試験の概要

第6章 冠状動脈ガイドワイヤー - 最近の発展

第7章 付録

Abstract

GlobalData's Medical Devices sector report, "Coronary Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Coronary Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Coronary Guidewires under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Coronary Guidewires under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Coronary Guidewires Overview

3 Products under Development

• 3.1 Coronary Guidewires - Pipeline Products by Stage of Development
• 3.2 Coronary Guidewires - Pipeline Products by Territory
• 3.3 Coronary Guidewires - Pipeline Products by Regulatory Path
• 3.4 Coronary Guidewires - Pipeline Products by Estimated Approval Date
• 3.5 Coronary Guidewires - Ongoing Clinical Trials

4 Coronary Guidewires - Pipeline Products under Development by Companies

• 4.1 Coronary Guidewires Companies - Pipeline Products by Stage of Development
• 4.2 Coronary Guidewires - Pipeline Products by Stage of Development

5 Coronary Guidewires Companies and Product Overview

• 5.1 Abbott Vascular Inc Company Overview
  • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 APT Medical Inc Company Overview
  • 5.2.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Bioscan Technologies Inc. Company Overview
  • 5.3.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Boston Scientific Corp Company Overview
  • 5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Cardiovascular Systems Inc Company Overview
  • 5.5.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 CorMetrics LLC Company Overview
  • 5.6.1 CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Echopoint Medical Ltd Company Overview
  • 5.7.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 ENDOMATERIALS Company Overview
  • 5.8.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Georgia Institute of Technology Company Overview
  • 5.9.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Guided Interventions, LLC Company Overview
  • 5.10.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Infrared Sciences Corp Company Overview
  • 5.11.1 Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Koninklijke Philips NV Company Overview
  • 5.12.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 MaRVis Technologies GmbH Company Overview
  • 5.13.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Microbot Medical Ltd Company Overview
  • 5.14.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 MicroPort Scientific Corp Company Overview
  • 5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 NewMed Medical Co Ltd Company Overview
  • 5.16.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Nirtek Pty Ltd Company Overview
  • 5.17.1 Nirtek Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Opsens Inc Company Overview
  • 5.18.1 Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 OVALUM Ltd Company Overview
  • 5.19.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 SoundBite Medical Solutions Inc Company Overview
  • 5.20.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 St. Jude Medical LLC Company Overview
  • 5.21.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Terumo Corp Company Overview
  • 5.22.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Terumo Interventional Systems Company Overview
  • 5.23.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 The Cleveland Clinic Foundation Company Overview
  • 5.24.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Three Rivers Cardiovascular Systems Inc Company Overview
  • 5.25.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Transmural systems LLC Company Overview
  • 5.26.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 University of Illinois at Chicago Company Overview
  • 5.27.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 Vasostar Ltd. Company Overview
  • 5.28.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6 Coronary Guidewires- Recent Developments

• 6.1 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
• 6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
• 6.3 Feb 14, 2023: Asahi Intecc Announces Consolidated Financial Results for the Six Months Ended December 31, 2022
• 6.4 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
• 6.5 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
• 6.6 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
• 6.7 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
• 6.8 Jan 12, 2023: OpSens Announces Record First Quarter fiscal 2023 Financial Results
• 6.9 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
• 6.10 Nov 23, 2022: Medtronic Reports Quarterly Earnings
• 6.11 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
• 6.12 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
• 6.13 Nov 11, 2022: Asahi Intecc Consolidated Financial Results for the Three Months Ended September 30, 2022
• 6.14 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
• 6.15 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
• 6.16 Sep 07, 2022: Medtronic to appear at September investor conferences
• 6.17 Sep 06, 2022: Occlutech Appoints Chief Commercial Officer and Vice President Global Business Development & Marketing
• 6.18 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
• 6.19 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
• 6.20 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
• 6.21 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
• 6.22 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
• 6.23 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
• 6.24 Jul 14, 2022: Opsens Announces Third Quarter Fiscal 2022 Financial Results With Record Quarterly Revenues
• 6.25 Jul 12, 2022: Opsens Set to Announce Earnings on Thursday
• 6.26 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region
• 6.27 Jul 07, 2022: Opsens to Host Third Quarter Fiscal Year 2022 Financial Results Conference Call on Thursday, July 14
• 6.28 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
• 6.29 Jun 23, 2022: Cleveland Clinic Appoints Alex A. Adjei, M.D., Ph.D., as Chair of Taussig Cancer Institute
• 6.30 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
• 6.31 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
• 6.32 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
• 6.33 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
• 6.34 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022
• 6.35 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer